分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

FBXO32 activates the PI3K/AKT pathway by inhibiting PTEN through ubiquitination of TAL1 in hepatocellular carcinoma

Yujie Xiong, Xuefeng Yang, Ting Cao

Journal:BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

IF:4.3

DOI:10.1016/j.bbamcr.2026.120125

PMID:

Published:2026-02-17

research field:肿瘤学分子生物学癌症研究泛素-蛋白酶体系统细胞信号转导

Abstract

The role of E3 ubiquitin ligases in cellular mechanisms and cancer progression is critical. In this study, our primary objective was to elucidate the functional consequences of F-box only protein 32 (FBXO32) in the progression and metastasis of hepatocellular carcinoma (HCC) and to clarify the signaling networks. FBXO32 was highly expressed, and T-cell acute lymphocytic leukemia protein 1 (TAL1) was poorly expressed in HCC cells relative to THLE-2 cells. FBXO32 interacted with the TAL1 protein and degraded TAL1. Knocking down FBXO32 suppressed epithelial-mesenchymal transition and the PTEN/PI3K/AKT signaling in MHCC-97H cells, while knocking down TAL1 reversed this effect. Similarly, overexpression of FBXO32 in SNU-398 cells promoted HCC progression, and reactivation of TAL1 also reversed this trend. Importantly, HCC patients with high FBXO32 or low TAL1 expression were both associated with poor prognosis. Our study has shown that FBXO32 facilitates HCC growth and metastasis via the PTEN/PI3K/AKT signaling through ubiquitination of TAL1. Consequently, FBXO32 emerges as a promising target for therapeutic intervention in the treatment of HCC.

本文使用的Yeasen产品

购物车
客服
转染试用